Ampio Pharmaceuticals
AMPE
#10508
Rank
HK$2.48 M
Marketcap
HK$2.19
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

EPS for Ampio Pharmaceuticals (AMPE)

EPS in 2023 (TTM): -HK$133.71

According to Ampio Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -HK$133.38. In 2022 the company made an earnings per share (EPS) of -HK$169.69 an increase over its 2021 EPS that were of -HK$211.33.

EPS history for Ampio Pharmaceuticals from 2006 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$133.71-21.21%
2022-HK$169.69-19.7%
2021-HK$211.33-0%
2020-HK$211.33-10%
2019-HK$234.82-121.74%
2018HK$1,080-158.23%
2017-HK$1,855119.44%
2016-HK$845.34-41.94%
2015-HK$1,456-18.42%
2014-HK$1,78520.63%
2013-HK$1,47985.29%
2012-HK$798.37-52.11%
2011-HK$1,66744.9%
2010-HK$1,151390%
2009-HK$234.82233.33%
2008-HK$70.44-0%
2007-HK$70.44
2006N/A

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$87.17-165.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$10.64-107.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$29.34-122.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
HK$337.51-353.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Rigel Pharmaceuticals
RIGL
HK$49.55-137.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-HK$5.87-95.60%๐Ÿ‡บ๐Ÿ‡ธ USA